Are novel glucose-lowering agents' cardiorenal benefits generalizable to individuals of Black race? A meta-trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment

Affiliations

• ¹ Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, Florida, USA.
• ² Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, Florida, USA.
• ³ Division of Clinical Pharmacy, University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California, USA.
• ⁴ Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
• ⁵ Division of Endocrinology, Diabetes, and Metabolism, University of Florida, Gainesville, Florida, USA.
• ⁶ Center for Drug Evaluation and Safety, University of Florida, Gainesville, Florida, USA.
• ⁷ Department of Pharmacy, Peking University Third Hospital, Beijing, China.
• ⁸ Division of Cardiology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.